Pathologic disruption of mRNA co-expression patterns supports the notion of a cross talk between IGF1, EGF, and FGF2 signaling pathways in the promotion of endothelial cell proliferation and differentiation of endometrial cancer (44). This evidence concerns the gene FGF2 and endometrial cancer.